US Patent Issued to Newsoara Biopharmaceutical Technology (Suzhou) on Sept. 1 for "TL1A-binding molecules, IL-23p19-binding molecules, and bispecific antigen-binding molecules, and uses thereof" (Chinese Inventors)

Posted On: 2026-09-01

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,093, issued on Sept. 1, was assigned to Newsoara Biopharmaceutical Technology (Suzhou) Co. Ltd. (JiangSu, China). "TL1A-binding molecules, ... Read More

US Patent Issued to Regents of the University of Minnesota on Sept. 1 for "Anti-DR5 polypeptides and methods of use thereof" (Minnesota Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,094, issued on Sept. 1, was assigned to Regents of the University of Minnesota (Minneapolis). "Anti-DR5 polypeptides and methods of use the... Read More

US Patent Issued to MERUS on Sept. 1 for "Methods of treating cancer using binding molecules that bind CD137 and PD-L1" (Dutch Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,095, issued on Sept. 1, was assigned to MERUS N.V. (Utrecht, Netherlands). "Methods of treating cancer using binding molecules that bind CD... Read More

US Patent Issued to Novartis on Sept. 1 for "Regimens and methods of treating multiple sclerosis using ofatumumab" (Swiss, American Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,096, issued on Sept. 1, was assigned to Novartis AG (Basel, Switzerland). "Regimens and methods of treating multiple sclerosis using ofatum... Read More

US Patent Issued to Regeneron Pharmaceuticals on Sept. 1 for "Anti-CD45 antibody drug conjugates and uses thereof" (Massachusetts Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,097, issued on Sept. 1, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Anti-CD45 antibody drug conjugates and uses ther... Read More

US Patent Issued to CRAGE MEDICAL on Sept. 1 for "Anti-claudin 18.2 antibody and use thereof" (Chinese Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,098, issued on Sept. 1, was assigned to CRAGE MEDICAL Co. Ltd. (Hong Kong). "Anti-claudin 18.2 antibody and use thereof" was invented by Zo... Read More

US Patent Issued to JANUX THERAPEUTICS on Sept. 1 for "Tumor activated antibodies targeting TROP2 and uses thereof" (California Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,099, issued on Sept. 1, was assigned to JANUX THERAPEUTICS INC. (San Diego). "Tumor activated antibodies targeting TROP2 and uses thereof" ... Read More

US Patent Issued to CSPC MEGALITH BIOPHARMACEUTICAL on Sept. 1 for "Nectin-4 antibodies and uses thereof" (Pennsylvania, New Jersey, California Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,100, issued on Sept. 1, was assigned to CSPC MEGALITH BIOPHARMACEUTICAL Co. LTD. (Shijiazhuang, China). "Nectin-4 antibodies and uses there... Read More

US Patent Issued to Numab Therapeutics on Sept. 1 for "Antibody specifically binding to human serum albumin" (Swiss, French Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,101, issued on Sept. 1, was assigned to Numab Therapeutics AG (Horgen, Switzerland). "Antibody specifically binding to human serum albumin"... Read More

US Patent Issued to UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY on Sept. 1 for "Composition for differential diagnosis of Acanthamoeba keratitis comprising chorismate mutase protein antibodies, and Acanthamoeba keratitis diagnosis kit using same" (South Korean Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,102, issued on Sept. 1, was assigned to UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (Yongin-si, South Korea). "Compositio... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to Newsoara Biopharmaceutical Technology (Suzhou) on Sept. 1 for "TL1A-binding molecules, IL-23p19-binding molecules, and bispecific antigen-binding molecules, and uses thereof" (Chinese Inventors)

US Patent Issued to Regents of the University of Minnesota on Sept. 1 for "Anti-DR5 polypeptides and methods of use thereof" (Minnesota Inventors)

US Patent Issued to MERUS on Sept. 1 for "Methods of treating cancer using binding molecules that bind CD137 and PD-L1" (Dutch Inventors)

US Patent Issued to Novartis on Sept. 1 for "Regimens and methods of treating multiple sclerosis using ofatumumab" (Swiss, American Inventors)

US Patent Issued to Regeneron Pharmaceuticals on Sept. 1 for "Anti-CD45 antibody drug conjugates and uses thereof" (Massachusetts Inventors)

US Patent Issued to CRAGE MEDICAL on Sept. 1 for "Anti-claudin 18.2 antibody and use thereof" (Chinese Inventors)

US Patent Issued to JANUX THERAPEUTICS on Sept. 1 for "Tumor activated antibodies targeting TROP2 and uses thereof" (California Inventors)

US Patent Issued to CSPC MEGALITH BIOPHARMACEUTICAL on Sept. 1 for "Nectin-4 antibodies and uses thereof" (Pennsylvania, New Jersey, California Inventors)

US Patent Issued to Numab Therapeutics on Sept. 1 for "Antibody specifically binding to human serum albumin" (Swiss, French Inventors)

US Patent Issued to UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY on Sept. 1 for "Composition for differential diagnosis of Acanthamoeba keratitis comprising chorismate mutase protein antibodies, and Acanthamoeba keratitis diagnosis kit using same" (South Korean Inventors)